Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 213584
Company: SUN PHARMA CANADA
Company: SUN PHARMA CANADA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| OXYMETAZOLINE HYDROCHLORIDE | OXYMETAZOLINE HYDROCHLORIDE | 1% | CREAM;TOPICAL | Prescription | AB | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 10/04/2021 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/213584Orig1s000ltr.pdf |
OXYMETAZOLINE HYDROCHLORIDE
CREAM;TOPICAL; 1%
TE Code = AB
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| OXYMETAZOLINE HYDROCHLORIDE | OXYMETAZOLINE HYDROCHLORIDE | 1% | CREAM;TOPICAL | Prescription | No | AB | 213584 | SUN PHARMA CANADA |
| RHOFADE | OXYMETAZOLINE HYDROCHLORIDE | 1% | CREAM;TOPICAL | Prescription | Yes | AB | 208552 | MAYNE PHARMA |